Author: Ken Dropiewski

Hoag Now Offers the Most Comprehensive Aortic Disease Center in Southern California

– Renowned Stanford University specialist joins Hoag to bring care for Marfan Syndrome and Related Conditions to the Jeffrey M. Carlton Heart & Vascular Institute – Hoag Presenting Sponsor of the Marfan Foundation Southern California Walk for Victory in February 2020 NEWPORT BEACH, Calif., Feb. 10, 2020 /PRNewswire/ — Hoag’s Jeffrey M. […]

Metactive Medical Announces Name Change to Artio Medical

FAIRWAY, Kan., Feb. 11, 2020 /PRNewswire/ — Metactive Medical, Inc., a medical device company developing innovative products for peripheral vascular and neurovascular diseases, announced today that it has changed its name to Artio Medical, Inc. effective immediately. “The corporate name change marks an important milestone as we progress toward commercialization,” said F. Nicholas Franano, […]

Neovasc Initiates Independent Inquiry Into Trading of its Shares

Vancouver, Feb. 11, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today that the Company has […]

Philips announces DEFINE GPS global multicenter study to assess outcomes of PCI procedures guided by integrated iFR and interventional X-ray images

Randomized controlled trial with up to 3,000 participants at 75 sites to compare outcomes between physiological guidance by iFR data co-registered on the angiogram (interventional X-ray image) versus the standard of care use of an angiogram alone Percutaneous coronary intervention (PCI) is one of the main treatment options to open […]

PhaseBio Announces European Regulatory Update for PB2452

PB2452 granted PRIME Designation by the European Medicines Agency PhaseBio receives written scientific advice confirming PB2452 clinical development plan In Phase 1 and Phase 2a clinical trials, PB2452 provided immediate and sustained reversal of the antiplatelet effects of ticagrelor MALVERN, Pa. and SAN DIEGO, Feb. 11, 2020 (GLOBE NEWSWIRE) — PhaseBio […]

VADovations, Inc. Secures Investment and Development Agreement for a Percutaneous Endovascular Delivery System for its Next-Generation Cardiac Assist Device for Long-Term Use

OKLAHOMA CITY–(BUSINESS WIRE)–VADOVATIONS, Inc., a company developing miniaturized cardiac assist pumps offering best-in-class blood handling properties, high performance and low cost, today announces an agreement with a strategic partner to both invest in the Company and develop a percutaneous endovascular delivery system for VADovations’ novel cardiac assist pump for long-term use […]

JenaValve Technology Closes $50 Million Financing

IRVINE, Calif.–(BUSINESS WIRE)–JenaValve Technology, Inc., developer and manufacturer of the JenaValve Pericardial Transcatheter Aortic Valve Replacement (TAVR) System for the treatment of aortic valve disease, announces that it has raised $50 million in an equity financing led by Bain Capital Life Sciences. Additional participants in the financing included existing investors Andera […]

AngioDynamics Appoints Stephen Trowbridge Executive Vice President and Chief Financial Officer

AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has appointed Stephen Trowbridge to the role of Executive Vice President and Chief Financial Officer, effective February 5, 2020. Mr. Trowbridge has served as the […]

Hemostemix Announces the Appointment of Dr. Ronnie Hershman to the Board of Directors and Provides a Corporate Update

CALGARY, Alberta, Feb. 10, 2020 (GLOBE NEWSWIRE) — Hemostemix Inc. (“Hemostemix” or the “Company”) (TSXV: HEM; OTC: HMTXF) is pleased to announce the appointment of Dr. Ronnie Hershman, M.D., F.C.C.S., to its Board of Directors. Dr. Hershman is a successful, practicing cardiologist with over three decades of experience. Dr. Hershman […]